{"nct_id":"NCT00818662","title":"A Phase 3 Study Evaluating Safety and Effectiveness of Immune Globulin Intravenous (IGIV 10%) for the Treatment of Mild-to-Moderate Alzheimer´s Disease","status":"COMPLETED","status_verified_date":"2021-04","start_date":"2008-12-19","start_date_type":"ACTUAL","primary_completion_date":"2012-12-10","primary_completion_date_type":"ACTUAL","completion_date":"2012-12-10","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["TAK"]}